Cargando…
Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes
There is increasing evidence that deficient clearance of β-amyloid (Aβ) contributes to its accumulation in late-onset Alzheimer disease (AD). Several Aβ-degrading enzymes, including neprilysin (NEP), endothelin-converting enzyme (ECE), and angiotensin-converting enzyme (ACE) reduce Aβ levels and pro...
Autores principales: | Miners, J. Scott, Palmer, Jennifer C., Tayler, Hannah, Palmer, Laura E., Ashby, Emma, Kehoe, Patrick G., Love, Seth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4160973/ https://www.ncbi.nlm.nih.gov/pubmed/25309424 http://dx.doi.org/10.3389/fnagi.2014.00238 |
Ejemplares similares
-
Zibotentan, an Endothelin A Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintains Cerebral Perfusion
por: Palmer, Jennifer C., et al.
Publicado: (2020) -
Elevated late-life blood pressure may maintain brain oxygenation and slow amyloid-β accumulation at the expense of cerebral vascular damage
por: Tayler, Hannah M, et al.
Publicado: (2023) -
Mediators of cerebral hypoperfusion and blood‐brain barrier leakiness in Alzheimer’s disease, vascular dementia and mixed dementia
por: Tayler, Hannah, et al.
Publicado: (2021) -
Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
por: Barker, Rachel, et al.
Publicado: (2014) -
Angiotensin-converting enzyme 2 is reduced in Alzheimer’s disease in association with increasing amyloid-β and tau pathology
por: Kehoe, Patrick Gavin, et al.
Publicado: (2016)